MDXG (MiMedx Group) Inventory Turnover: 0.67 (As of Mar. 2026)

What is MiMedx Group Inventory Turnover?

MiMedx Group MDXG +1.15% 53 Inventory Turnover is 0.67 as of Mar. 2026. GuruFocus rates MDXG with a GF Score™ of 53/100 and a GF Value™ of $6.91 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. MiMedx Group's Cost of Goods Sold for the three months ended in Mar. 2026 was $17.4 Mil. MiMedx Group's Average Total Inventories for the quarter that ended in Mar. 2026 was $25.8 Mil. MiMedx Group's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.67.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. MiMedx Group's Days Inventory for the three months ended in Mar. 2026 was 135.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. MiMedx Group's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.44.

MiMedx Group (NAS:MDXG) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MiMedx Group's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	25.784	/	17.368	*	365 / 4
	=	135.47

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MiMedx Group's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	25.784	/	58.991
	=	0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

MiMedx Group Inventory Turnover Related Terms

MiMedx Group Inventory Turnover Historical Data

* Premium members only.

The historical data trend for MiMedx Group's Inventory Turnover can be seen below:

MiMedx Group Inventory Turnover Chart

MiMedx Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

3.64

3.93

3.19

2.68

2.97

MiMedx Group Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.69	0.76	0.73	0.74	0.67

53GF Score

MiMedx Group Inc MDXG

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

MiMedx Group Inventory Turnover Calculation

MiMedx Group's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	73.013	/ (	(23.807	+	25.34)	/	2 )
=	73.013	/	24.5735
=	2.97

MiMedx Group's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	17.368	/ (	(25.34	+	26.228)	/	2 )
=	17.368	/	25.784
=	0.67

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.67 mean?

MiMedx Group (MDXG) has a Inventory Turnover of 0.67 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on MiMedx Group and its competitors.

Is MiMedx Group's Inventory Turnover too high?

MiMedx Group's current Inventory Turnover is 0.67. Overall, MiMedx Group has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does MiMedx Group's Inventory Turnover compare to MNPR and FTH?

MiMedx Group's Inventory Turnover of 0.67 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on MiMedx Group and its competitors. MiMedx Group's current Inventory Turnover is 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is MiMedx Group stock overvalued right now?

Based on GuruFocus' analysis, MiMedx Group (MDXG) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.91, compared to a current price of $3.95 — trading 42.8% below its estimated fair value. The current Inventory Turnover is 0.67. MiMedx Group's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For MiMedx Group (MDXG), the current Inventory Turnover is 0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MiMedx Group (MDXG) Overvalued in 2026?

Based on GuruFocus' analysis, MiMedx Group stock appears to be undervalued. The current stock price of $3.95 is trading 42.8% below its estimated GF Value™ of $6.91. GuruFocus considers MiMedx Group to be Significantly Undervalued.

Key valuation signals for MDXG:

Inventory Turnover: 0.67
GF Value™: $6.91 vs. price of $3.95 (42.8% below fair value)
GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the MDXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MiMedx Group Business Description

Industry Healthcare Biotechnology

Comparable Companies MNPR FTH BBOT TECX FDMT TRAX ACHV STTK CRMD EIKN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1775 West Oak Commons Court, NE, Marietta, GA, USA, 30062

Website https://www.mimedx.com

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

53GF Score

Get the complete analysis for MDXG

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95

Price

$6.91

GF Value

View MDXG Analysis

See Inventory Turnover data for all stocks →